Lv32
226 积分 2025-09-28 加入
Discovery of (2R)-N-[3-[2-[(3-Methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propenamide (AZD4205) as a Potent and Selective Janus Kinase 1 Inhibitor
21天前
已完结
[Guidelines for the prevention and management of bronchial asthma (2024 edition)]
22天前
已完结
慢性阻塞性肺疾病诊治指南
22天前
已完结
中国慢性阻塞性肺疾病诊治指南（2026年修订版）计划书
22天前
已关闭
The metabolism of the dual orexin receptor antagonist daridorexant
1个月前
已完结
PD-1–targeted IL-15 mutein activates CD8+ and CD4+ T cells in infection and cancer
1个月前
已完结
Abstract PD10-10: A Multicenter, Open-Label, Phase 2 Study of nab-Sirolimus (HB1901) Plus Endocrine Therapy in HR+/HER2- Advanced Breast Cancer Following Standard Therapy Failure
1个月前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
1个月前
已完结
A theoretical insight into selectivity of inhibitors toward two domains of bromodomain‐containing protein 4 using molecular dynamics simulations
1个月前
已完结
Pharmacological properties of S1RA, a new sigma‐1 receptor antagonist that inhibits neuropathic pain and activity‐induced spinal sensitization
1个月前
已完结
皖公网安备34019202002308
